BUB
BIIB icon

BBVA USA Bancshares’s Biogen BIIB Stock Holding History

BBVA USA Bancshares’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,300
Closed -$538K – 386
2019
Q2 		$538K Sell
2,300
-1,907
-45% -$440K 0.03% 356
2019
Q1 		$994K Sell
4,207
-396
-9% -$125K 0.06% 249
2018
Q4 		$1.39M Sell
4,603
-287
-6% -$91.6K 0.1% 193
2018
Q3 		$1.73M Buy
4,890
+928
+23% +$320K 0.1% 194
2018
Q2 		$1.15M Sell
3,962
-41
-1% -$11.5K 0.07% 231
2018
Q1 		$1.1M Sell
4,003
-840
-17% -$261K 0.07% 244
2017
Q4 		$1.54M Sell
4,843
-211
-4% -$67.7K 0.1% 204
2017
Q3 		$1.58M Sell
5,054
-20
-0.4% -$5.92K 0.1% 192
2017
Q2 		$1.38M Buy
5,074
+134
+3% +$35.4K 0.09% 214
2017
Q1 		$1.35M Buy
4,940
+411
+9% +$116K 0.09% 217
2016
Q4 		$1.28M Buy
4,529
+91
+2% +$27K 0.09% 218
2016
Q3 		$1.39M Buy
4,438
+234
+6% +$69.3K 0.1% 193
2016
Q2 		$1.02M Sell
4,204
-204
-5% -$53.8K 0.08% 236
2016
Q1 		$1.15M Buy
4,408
+1,026
+30% +$271K 0.09% 227
2015
Q4 		$1.04M Buy
3,382
+801
+31% +$230K 0.08% 223
2015
Q3 		$753K Buy
2,581
+67
+3% +$22.1K 0.06% 257
2015
Q2 		$1.02M Sell
2,514
-64
-2% -$25.7K 0.06% 243
2015
Q1 		$1.09M Buy
2,578
+41
+2% +$16.2K 0.05% 267
2014
Q4 		$861K Buy
2,537
+183
+8% +$59.2K 0.04% 311
2014
Q3 		$779K Sell
2,354
-4
-0.2% -$1.32K 0.03% 312
2014
Q2 		$744K Buy
2,358
+1,683
+249% +$507K 0.03% 320
2014
Q1 		$206K Buy
+675
New +$214K 0.01% 520

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BBVA USA Bancshares's BIIB Position: Q3 2019 in Review

BBVA USA Bancshares sold out of Biogen (BIIB) in Q3 2019, closing a stake of 2,300 shares — an estimated $538K sold.

BBVA USA Bancshares first reported a position in BIIB in Q1 2014 and held it in 22 quarters. The position peaked at $1.73M in Q3 2018. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • BBVA USA Bancshares reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
  • BBVA USA Bancshares sold 2,300 Biogen shares in Q3 2019, an estimated $538K.
  • BBVA USA Bancshares first reported a position in Biogen in Q1 2014 and held it in 22 quarters.
  • BBVA USA Bancshares's Biogen position peaked at $1.73M in Q3 2018.
  • 989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on BBVA USA Bancshares's 13F filing for Q3 2019, filed 5 Nov 2019.